Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gekle

Showing results (31-40 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Pharmacology|December 22, 2021
Mineralocorticoid receptors in non-alcoholic fatty liver diseaseBarbara Schreier, Alexander Zipprich, Henriette Uhlenhaut, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 8, 2004
A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substancesFlorian Weber, Ruth Freudinger, Gerald Schwerdt, et al.
Steroids|November 3, 2009
Interaction between mineralocorticoid receptor and cAMP/CREB signalingClaudia Grossmann, Stefanie Ruhs, Anja Seiferth, et al.
RNA Biology|January 6, 2021
Identification and initial characterization of POLIII-driven transcripts by msRNA-sequencingPeter Zorn, Danny Misiak, Michael Gekle, et al.
American Journal of Nephrology|June 20, 2014
Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injuryAriane Bischoff, Michael Bucher, Michael Gekle, et al.
Advances in Physiology Education|July 23, 2020
A hydraulic model of cardiovascular physiology and pathophysiology embedded into a computer-based teaching system for student training in laboratory coursesAndreas Christ, Dieter Barowsky, Michael Gekle, et al.
Toxicology|August 6, 2014
Role of microRNA-29b in the ochratoxin A-induced enhanced collagen formation in human kidney cellsIsabell Hennemeier, Hans-Ulrich Humpf, Michael Gekle, et al.
Biochemical Pharmacology|July 12, 2021
Angiotensin II receptor type 1 - An update on structure, expression and pathologyRobert Eckenstaler, Jana Sandori, Michael Gekle, et al.
Journal of Proteome Research|July 28, 2015
Acidosis-Induced Changes in Proteome Patterns of the Prostate Cancer-Derived Tumor Cell Line AT-1Angelika Ihling, Christian H Ihling, Andrea Sinz, et al.
Advances in Experimental Medicine and Biology|February 23, 2008
Activity of drug efflux transporters in tumor cells under hypoxic conditionsOliver Thews, Birgit Gassner, Debra K Kelleher, et al.
Pageof 17

Showing results (31-40 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Pharmacology|December 22, 2021
Mineralocorticoid receptors in non-alcoholic fatty liver diseaseBarbara Schreier, Alexander Zipprich, Henriette Uhlenhaut, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 8, 2004
A rapid screening method to test apoptotic synergisms of ochratoxin A with other nephrotoxic substancesFlorian Weber, Ruth Freudinger, Gerald Schwerdt, et al.
Steroids|November 3, 2009
Interaction between mineralocorticoid receptor and cAMP/CREB signalingClaudia Grossmann, Stefanie Ruhs, Anja Seiferth, et al.
RNA Biology|January 6, 2021
Identification and initial characterization of POLIII-driven transcripts by msRNA-sequencingPeter Zorn, Danny Misiak, Michael Gekle, et al.
American Journal of Nephrology|June 20, 2014
Differential effect of COX1 and COX2 inhibitors on renal outcomes following ischemic acute kidney injuryAriane Bischoff, Michael Bucher, Michael Gekle, et al.
Advances in Physiology Education|July 23, 2020
A hydraulic model of cardiovascular physiology and pathophysiology embedded into a computer-based teaching system for student training in laboratory coursesAndreas Christ, Dieter Barowsky, Michael Gekle, et al.
Toxicology|August 6, 2014
Role of microRNA-29b in the ochratoxin A-induced enhanced collagen formation in human kidney cellsIsabell Hennemeier, Hans-Ulrich Humpf, Michael Gekle, et al.
Biochemical Pharmacology|July 12, 2021
Angiotensin II receptor type 1 - An update on structure, expression and pathologyRobert Eckenstaler, Jana Sandori, Michael Gekle, et al.
Journal of Proteome Research|July 28, 2015
Acidosis-Induced Changes in Proteome Patterns of the Prostate Cancer-Derived Tumor Cell Line AT-1Angelika Ihling, Christian H Ihling, Andrea Sinz, et al.
Advances in Experimental Medicine and Biology|February 23, 2008
Activity of drug efflux transporters in tumor cells under hypoxic conditionsOliver Thews, Birgit Gassner, Debra K Kelleher, et al.
Pageof 17